Navigate Emerging Tech & AI Challenges & Opportunities, Close The Loop With Patient Feedback To Transform Patient Experiences & Make Tangible Improvements To Outcomes By Building Multi-Stakeholder Trust, Overcoming Resistance & Strengthening Partnerships With
Embrace Innovative New Thinking To Break Down Barriers & Build Future-Focused, Value-Driven & Impactful Patient Centricity, Engagement & Collaboration
8th Annual, One-Day, Industry-Led Conference & Networking Exhibition, London, 24th June 2026 – Written In Collaboration With Patients, Advocacy Groups & The Pharmaceutical Industry
08.15 Registration & Informal Networking
OPENING REMARKS
09.00 GIC Welcome & Morning Co-Chairs’ Opening Remarks
Narinder Chopra, Patient Engagement XTA Head, Johnson & Johnson
Anthony Cuncliffe, National Lead Medical Adviser, Macmillan Cancer Support
Overcoming Barriers To Patient Centricity
09.10 Put Your Patients At The Core & Break Through Barriers By Streamlining Pathways & Elevating Early Patient Involvement To Truly Drive Patient-Centric Decision-Making
- Prioritise meaningful, patient-centred conversations to overcome heavy workloads, time pressures and short appointments that limit opportunities for shared decision-making
- How can we untangle the “dizzying maze” of pharma and healthcare systems; hospitals, clinics, and pharmacies so patients aren’t met with mixed messages or repeated steps along the way?
- Late-stage involvement leaves patients feeling unheard! Embed patient voices into trial design, endpoint selection and communication planning right from the start
Soraya Clarke, Strategic Participation Manager, Macmillan Cancer Support
Patient Involvement In HTA
PANEL Q&A
09.30 Overcome HTA Obstacles With Earlier Patient Input, Stronger Real-World Evidence & Collaborative Approaches That Elevate What Truly Matters To Patients In 2026 & Beyond
- How can pharma ensure patient voices genuinely influence HTA frameworks, evidence requirements and value assessments, and not just appear as an add-on?
- As HTA bodies demand more patient-centred evidence, unpack how pharma can partner with patients earlier to strengthen dossiers and reflect what truly matters to those needing the support
- Analyse the barriers to effective patient input in HTA to explore how to overcome hurdles and learn from impactful case studies where patient voices have driven change across Europe
Jose Diaz, Global HEOR, Health Systems Economics & Value of Innovation, Bristol Myers Squibb
Hamda Munawar, Senior Manager European Oncology Patient Advocacy, Daiichi Sankyo Europe GmbH
Sujan Sivasubramaniyam, Senior Director, Head of Global Patient Advocacy & Policy, CSL
